Seven positions.
Each one GMC-defensible.

AI generates. Practitioners decide. Clinical responsibility never transfers to a platform.

VitalMatrix™ is a documentation tool. Every output is a working document generated for practitioner review. The practitioner applies clinical judgement, makes the clinical decision, and carries the clinical responsibility. This position is not a caveat. It is the architecture. The practitioner review gate is built into every output layer. Nothing reaches a patient without clinical sign-off.

Terrain framing is not an alternative to evidence. It is a different lens applied to the same evidence.

VitalMatrix™ uses terrain-based framing across all output documents: immune resilience, toxic burden, cellular protection, biological terrain. These are not proprietary interpretations. They are terrain-based language applied to peer-reviewed evidence. Every FLINT™ (Five-Layer Intelligence) layer includes evidence classification. The terrain lens does not replace evidence. It organises it differently.

Functional optimal ranges are documented in peer-reviewed literature. They are not proprietary claims.

The MedTerrain™ (Biomarker-to-Node Mapping) system uses functional optimal ranges rather than conventional reference intervals. Each range is referenced to peer-reviewed literature. Vitamin D at 40 ng/dL as a functional threshold is documented. Insulin OGTT functional ranges are documented. These are not VitalMatrix™ proprietary values. They are published values applied within terrain framing.

Every output carries a practitioner review gate. Nothing reaches a patient without clinical sign-off.

This is not optional functionality. The practitioner review gate is a structural element of every output generated by VitalMatrix™. CIB™ (Clinical Intelligence Briefs), TIQ™ (Terrain Intelligent Quotient) documents, CZR™ (Convergence Zone Reports), and all other output types are generated as practitioner-facing working documents. The route from platform to patient requires practitioner decision and sign-off at every stage.

Patient data belongs to the practitioner and patient. VitalMatrix™ holds it in trust.

Data governance is not a compliance exercise at VitalMatrix™. Patient data processed through the platform is held under ICO Registration ZC101813. GDPR obligations are structural. Data is not used to train models. It is not shared with third parties beyond the infrastructure required for platform operation. The practitioner retains data ownership. VitalMatrix™ operates as data processor, not data controller.

Phase discipline means not claiming capabilities that are not yet built. What VitalMatrix™ cannot do is as clearly stated as what it can.

Phase 1 capabilities are described as live because they are live. Phase 2 capabilities are badged as “Phase 2, Coming Soon” because they are not yet built. MatrixAssist AI, full protocol generation, drug-nutrient interaction screening, and LabAssist integration are Phase 2 capabilities. They are listed so practitioners can see where the platform is going. They are badged so no one is misled about where it is now. This is not a legal precaution. It is a clinical ethics position.

The platform is a documentation tool. It does not diagnose, prescribe, or replace the clinical encounter.

VitalMatrix™ generates documentation. It builds matrices. It maps convergence zones. It produces terrain-framed working documents. It does not diagnose. It does not prescribe. It does not replace the clinical encounter between practitioner and patient. The MHRA SaMD classification boundary is actively maintained. The platform was designed to operate within that boundary. Every capability is assessed against it before release.